Skip to the page

Data / Drug companies / Sulfone

Sulfone drugs: 6 drugs from 30 companies in the FDA NDC directory

Sulfone is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 51 products in this class from 30 companies, covering 6 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on July 8, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 30Companies
  • 51Products
  • 6Drugs by generic name

Drugs in the Sulfone class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Dapsone4426
Dapsone gel, 5%22
Dapsone tablets21
Dapsone 100mg11
Dapsone 25mg11
Daspone11

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Sun Pharmaceutical Industries, Inc.4gel; tabletGeneric drugs (ANDA)June 26, 2019
Westminster Pharmaceuticals, LLC4tabletGeneric drugs (ANDA)August 21, 2025
Viona Pharmaceuticals Inc3tablet; gelGeneric drugs (ANDA)February 27, 2026
Zydus Lifesciences Limited3tablet; gelGeneric drugs (ANDA)February 27, 2026
Alembic Pharmaceuticals Inc.2gelGeneric drugs (ANDA)July 1, 2026
Alembic Pharmaceuticals Limited2gelGeneric drugs (ANDA)July 1, 2026
Ani Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)January 15, 2018
Chartwell RX, LLC2tabletGeneric drugs (ANDA)May 10, 2016
Everest Life Sciences. LLC2tabletGeneric drugs (ANDA)September 1, 2024
Macleods Pharmaceuticals Limited2tabletGeneric drugs (ANDA)July 8, 2026
NorthStar Rx LLC2gelGeneric drugs (ANDA)October 6, 2023
Proficient Rx LP2tabletGeneric drugs (ANDA)August 21, 2025
Rising Pharma Holdings, Inc.2tabletGeneric drugs (ANDA)July 20, 2023
Solis Pharmaceuticals Inc.2tabletGeneric drugs (ANDA)May 9, 2016
TruPharma, LLC2gelGeneric drugs (ANDA)November 20, 2024
Almirall, LLC1gelNew drug applications (NDA)September 10, 2019
Amneal Pharmaceuticals LLC1gelGeneric drugs (ANDA)October 24, 2023
Amneal Pharmaceuticals NY LLC1gelGeneric drugs (ANDA)June 2, 2023
Aurobindo Pharma Limited1gelGeneric drugs (ANDA)April 4, 2025
AvKARE1tabletGeneric drugs (ANDA)December 10, 2025
AvKARE1tabletGeneric drugs (ANDA)March 6, 2024
Boswell Pharmacy Services LLC D/B/A BPS Wholesale1tabletGeneric drugs (ANDA)August 30, 2024
Cosette Pharmaceuticals, Inc.1gelGeneric drugs (ANDA)May 8, 2023
Coupler LLC1tabletGeneric drugs (ANDA)January 31, 2025
Encube Ethicals, Inc.1gelGeneric drugs (ANDA)October 16, 2023
Mayne Pharma1gelGeneric drugs (ANDA)February 11, 2022
Mayne Pharma Inc.1gelGeneric drugs (ANDA)February 14, 2024
Mylan Pharmaceuticals Inc.1gelGeneric drugs (ANDA)May 20, 2022
Pacific Pharma, Inc.1gelAuthorized generics (NDA)October 18, 2017
Torrent Pharmaceuticals Limited1gelGeneric drugs (ANDA)February 10, 2022

Dosage forms

Dosage formProductsShare
Tablet2854.9%
Gel2345.1%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.